Cortex Discovery
PrivateCompany Overview
Cortex Discovery is a biotechnology company that provides AI-driven drug discovery services, including virtual high-throughput screening and ADMET profiling, to accelerate preclinical drug development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Foundation
Keywords
drug discoveryin-silico drug discoveryAI drug discoveryfoundation modelvirtual high-throughput screeningvHTSADME-Tox predictionde novo compound generationmolecular property predictionpreclinical researchlead optimizationfrontier AI labcomputational biologycheminformaticsAI-native biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cortex Discovery Comparables
Compare Cortex Discovery with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anyo Labs | 89% | |
| Genesis Molecular AI | 79% | |
| Terray Therapeutics | 78% | |
Cortex Discovery Funding Rounds
Historical fundraising activity
Cortex Discovery Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cortex Discovery's valuation, stock price, and market status.
See something wrong or outdated?